The worldwide recrudescence of tuberculosis and widespread antibiotic resistance have strengthened the need for the rapid development of new antituberculous drugs targeting essential functions of its etiologic agent, Mycobacterium tuberculosis. In our search for new targets, we found that the M. tuberculosis pps1 gene, which contains an intein coding sequence, belongs to a conserved locus of seven open reading frames. In silico analyses indicated that the mature Pps1 protein is orthologous to the SufB protein of many organisms, a highly conserved component of the [Fe-S] cluster assembly and repair SUF (mobilization of sulfur) machinery. We showed that the mycobacterial pps1 locus constitutes an operon which encodes Suf-like proteins. Interactions between these proteins were demonstrated, supporting the functionality of the M. tuberculosis SUF system. The noticeable absence of any alternative [Fe-S] cluster assembly systems in mycobacteria is in agreement with the apparent essentiality of the suf operon in Mycobacterium smegmatis. Altogether, these results establish that Pps1, as a central element of the SUF system, could play an essential function for M. tuberculosis survival virtually through its implication in the bacterial resistance to iron limitation and oxidative stress. As such, Pps1 may represent an interesting molecular target for new antituberculous drugs.According to the World Health Organization (http://www .who.int/en/), tuberculosis remains a major public health threat as a first-line infectious disease responsible for 2 to 3 million deaths worldwide annually. Furthermore, the recent recrudescence of infections with Mycobacterium tuberculosis, the causative agent of tuberculosis, is associated with the emergence of multidrug-resistant strains, which has strengthened the need for the rapid development of new antituberculous drugs. The discovery of essential functions of mycobacteria in pathways other than those targeted by present antibiotics appears thus to be necessary to efficiently fight tuberculosis.One singularity of the M. tuberculosis genome is the presence of intein insertion sequences in three genes, namely recA, dnaB, and pps1 (6, 9, 34). While the specificity of the recA and pps1 inteins of M. tuberculosis has been readily applied to the diagnosis of tuberculosis by PCR (46), the presence of an intein in a mycobacterial protein can present additional interest. Effectively, inteins are proteins embedded in-frame in a host protein; they are autocatalytically and posttranscriptionally excised from the peptide precursor to produce the functional host protein (26). Hence, the impediment of the protein splicing of a mycobacterial protein involved in a critical cellular process could represent an unusual way to kill M. tuberculosis (4,8,33).Among the intein-containing proteins, the mycobacterial RecA recombinase, while directly implied in DNA repair and homologous recombination (15, 31, 43), is not essential for the survival of Mycobacterium bovis BCG in a mouse infection model (43). An essenti...

The G238S substitution found in extended-spectrum natural mutants of TEM-1 beta-lactamase induces a new capacity to hydrolyze cefotaxime and a large loss of activity against the good substrates of TEM-1. To understand this phenomenon at the molecular level, a method to determine the acylation and deacylation elementary rate constants has been developed by using electrospray mass spectrometry combined with UV spectrophotometry. The hydrolysis of penicillins and cefotaxime by TEM-1 and the G238S mutant shows that the behavior of penicillins and cefotaxime is very different. With both enzymes, the limiting step is deacylation for penicillin hydrolysis, but acylation for cefotaxime hydrolysis. Further analyses of the G238S mutant show that the loss of activity against penicillins is due to a large decrease in the deacylation rate and that the increase in catalytic efficiency against cefotaxime is the result of a better Km and an increased acylation rate. These modifications of the elementary rate constants and the hydrolytic capacity in the G238S mutant could be linked to structural effects on the omega-loop conformation in the active site.

TEM-35 (inhibitor resistant TEM (IRT)-4) and TEM-36 (IRT-7) clavulanic acid-resistant beta-lactamases have evolved from TEM-1 beta-lactamase by two substitutions: a methionine to a leucine or a valine at position 69 and an asparagine to an aspartic acid at position 276. The substitutions at position 69 have previously been shown to be responsible for the resistance to clavulanic acid, and they are the only mutations encountered in TEM-33 (IRT-5) and TEM-34 (IRT-6). However, the N276D substitution has never been found alone in inhibitor-resistant beta-lactamases, and its role in resistance to clavulanic acid was thus unclear. The N276D mutant was constructed, purified, and kinetically characterized. It was shown that the substitution has a direct effect on substrate affinities and leads to slightly decreased catalytic efficiencies and that clavulanic acid becomes a poor substrate of the enzyme. Electrospray mass spectrometry demonstrated the simultaneous presence of free and inhibited enzymes after incubation with clavulanic acid and showed that a cleaved moiety of clavulanic acid leads to the formation of the major inactive complex. The kinetic properties of the N276D mutant could be linked to a salt-bridge interaction of aspartic acid 276 with arginine 244 that alters the electrostatic properties in the substrate binding area.

The SufBCD complex is an essential component of the SUF machinery of [Fe-S] cluster biogenesis in many organisms. We show here that in Mycobacterium tuberculosis the formation of this complex is dependent on the protein splicing of SufB, suggesting that this process is a potential new target for antituberculous drugs.The worldwide recrudescence of tuberculosis has been associated with the emergence of multidrug-resistant strains of Mycobacterium tuberculosis, its causative agent. This alarming situation has reinforced the need for the urgent development of new antituberculous drugs targeting novel and specific mycobacterial functions.In a recent work (7), we have identified the M. tuberculosis SUF (mobilization of sulfur) machinery as the unique and essential system of [Fe-S] cluster assembly in mycobacteria. This system is required for the maturation of physiologically important metalloproteins and plays an important role in the resistance to iron limitation and oxidative stress. It is encoded by a mycobacterial operon of seven genes, Rv1460 to Rv1466 (according to the M. tuberculosis genome annotation [5]), among which Rv1461 encoding the highly conserved SufB protein (7) is interrupted by an intein coding sequence (15).In the present study, we show the inability of the unspliced SufB protein to play its role in the SUF machinery owing to its inability to interact with some of its Suf partners. This highlights the prerequisite of protein splicing in SufB maturation and validates the SufB protein splicing as a specific molecular target for the development of novel antituberculous drugs since blocking the protein splicing process of essential proteins was proposed as a singular way to efficiently kill mycobacteria (1,3,6,14).Construction of a sufB mutant and expression of unspliced SufB. The Rv1461 open reading frame (ORF), encoding the M. tuberculosis SufB protein, was cloned in pGADT7 and pGBKT7 vectors (Clontech) for yeast two-hybrid assays (7). In these constructs, the Rv1461 gene was mutated in order to block the protein splicing process of the SufB precursor peptide: the asparagine residue at the C-terminal extremity of the intein sequence (position 611) and the adjacent cysteine (i.e., the first residue of the C-extein at position 612) were replaced by an aspartic acid and a valine, respectively. Site-directed mutagenesis was done using complementary oligonucleotide pairs (5Ј-TTGTAGATCGGTGCGGTGACGTCGTGCACGGCGAA CCCGT-3Ј and 5Ј-ACGGGTTCGCCGTGCACGACGTCAC CGCACCGATCTACAA-3Ј). To verify the protein splicing of the recombinant wild-type mycobacterial SufB protein when expressed in yeast and the blockage effect of the mutation, Saccharomyces cerevisiae strain AH109 (Clontech) was electrotransformed with the wild-type and mutated pGADT7 and pGBKT7 derivatives, plated, and grown at 30°C in minimal DOBA (dropout base with agar; BIO101) medium containing amino acid complement (Complete Supplement Mixture; BIO101) devoid of leucine (Leu) or tryptophan (Trp), to select transformed yeast cells. Two milliliters of a 1...